Key Takeaways Pfizer's $7.3B Metsera buyout faces a higher competing offer from Novo Nordisk.PFE has sued Metsera and Novo Nordisk over alleged breach of the merger agreement.Pfizer's new drug pricing deal with the Trump administration provides long-term clarity.On its third-quarter conference call held on Nov. 4, Pfizer (PFE) shed light on the two topics for which it has been in the news lately — the drug pricing deal with the Trump administration and the battle with Novo Nordisk (NVO) related to the Metse ...